What's Happening?
The International Organization for Standardization (ISO) has officially approved 'tomovircona' as the common name for a novel RNA interference (RNAi)-based virucide developed by Silicon Gene Technologies. This approval follows a public consultation process
with no objections raised. Tomovircona, previously known as SG-001, targets plant viruses with high specificity, using RNA interference to silence genes involved in disease development. This technology represents a new generation of crop protection, offering targeted disease management while minimizing impacts on non-target organisms. The approval adds to the growing list of RNAi-based technologies recognized internationally.
Why It's Important?
The approval of tomovircona marks a significant advancement in agricultural biotechnology, providing farmers with a new tool to combat plant viruses. This RNAi-based approach offers a more sustainable and environmentally friendly alternative to traditional pesticides, potentially reducing chemical use and its associated environmental impact. The technology's specificity could lead to more effective disease management, improving crop yields and food security. As the agricultural industry faces increasing pressure to adopt sustainable practices, innovations like tomovircona are crucial in meeting these demands while maintaining productivity.
